Search stocks

Find any stock by ticker or company name

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Instagram
Telegram
LinkedIn

Barcha huquqlar himoyalangan.

Foydalanish shartlari

Bosh sahifa
Kuzatuv
Bozorlar
Kalendar
Skriner
Yangiliklar
Biz haqimizda

BTMD - biote Corp. So'nggi Yangiliklar | Finranks

Home

/

BTMD

B

biote Corp. (BTMD)

NGM – Real vaqt narxi. Valyuta: USD

1.46

-0.08 (-5.19%)

Bozor ochiq: Aug 12, 2026, 2:11 PM EDT

1.54

+0.00 (0.06%)

Oldingi bozordan keyin: Aug 11, 2026, 7:22 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

biote Corp. (BTMD) Q2 2026 Earnings Call Transcript

biote Corp. (BTMD) Q2 2026 Earnings Call Transcript

biote Corp. (BTMD) Q2 2026 Earnings Call Transcript

biote Corp. (BTMD) Reports Break-Even Earnings for Q2

biote Corp. (BTMD) Reports Break-Even Earnings for Q2

biote Corp. (BTMD) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.03. This compares to earnings of $0.1 per share a year ago.

biote Q2 Earnings Call Highlights

biote Q2 Earnings Call Highlights

biote NASDAQ: BTMD reported lower second-quarter revenue and a net loss as a voluntary recall of certain hormone pellets supplied by Asteria Health disrupted procedure volumes, while management said supply conditions have since normalized and should support sequential improvement in the second half of 2026.

Biote Reports Second Quarter 2026 Financial Results

Biote Reports Second Quarter 2026 Financial Results

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners' patients, today announced financial results for the second quarter ended June 30, 2026. “Over the past year Biote has achieved meaningful progress in advancing our strategic initiatives, driving fundamental improvements that we believe position the Company to achieve sustainable procedure revenue growth,” said Bob Peterso.

Videolar

No Data

There is no data to display

Press-relizlar

Biote Reports Second Quarter 2026 Financial Results

Biote Reports Second Quarter 2026 Financial Results

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners' patients, today announced financial results for the second quarter ended June 30, 2026. “Over the past year Biote has achieved meaningful progress in advancing our strategic initiatives, driving fundamental improvements that we believe position the Company to achieve sustainable procedure revenue growth,” said Bob Peterso.